Home > Events > Past Conferences > 12th Annual Biomarkers and Clinical Research Congress

12th Annual Biomarkers and Clinical Research Congress

October 29-30, 2021 | Canada

12th Annual Biomarkers and Clinical Research Congress is anticipating participants from 40 and more countries across the globe and the two days conference will provoke plenary sessions, Keynote speeches, Poster, and Oral Presentations. This program provides two days of robust discussions on recent advancements and new strategies for development of new materials for global requirements.

Spotlight

Insights on Improving Global Drug Development from Bench to Commercialization

Although R&D spending on new drugs is high and the number of new INDs for small molecules and biologics continues to increase each year, the number of NDAs/BLAs submitted and approved by FDA has remained on average steady over the last 10 years.


OTHER PAST CONFERENCES

Traditional Medicine Ethnomedicine And Natural Therapies

May 18-19, 2022 | USA

Magnus Group cordially invites you to its “3rd Edition of International Conference on Traditional Medicine, Ethnomedicine and Natural Therapies” which is going to be held Virtually during May 18-19, 2022.

International Conference on Pharmacognosy

March 3-4, 2022 | France

Pharmaceutical and Pharmacognosy Sciences has wide scope in the world, thus has a vast and growing pharmaceutical industry and therapeutics. Increasing number of hospitals, nursing homes and pharmaceuticals companies all over the world is a clear indication of the growing scope in this area. Clinical research is related to the effectiveness and testing of medications, diagnostic products, medical devices and treatment procedures for human use.

INTERNATIONAL CONFERENCE ON MEDICAL, BIOLOGICAL AND PHARMACEUTICAL SCIENCES ICMBPS

March 12-13, 2022 | Gambia

The INTERNATIONAL CONFERENCE ON MEDICAL, BIOLOGICAL AND PHARMACEUTICAL SCIENCES ICMBPS. It will be held on 12th - 13th-Mar-2022 at Banjul, Gambia.

PRE FILLED SYRINGES EAST COAST

April 25-26, 2022 | USA

The global pre-filled syringes market was valued at $1139.6 million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. With that in mind, the 9th annual Pre-Filled Syringes East Coast conference will bring together leading industry experts representing big pharma and device developers to discuss the key drivers accelerating the expansion of the industry.

Traditional Medicine Ethnomedicine And Natural Therapies

May 18-19, 2022 | USA

Magnus Group cordially invites you to its “3rd Edition of International Conference on Traditional Medicine, Ethnomedicine and Natural Therapies” which is going to be held Virtually during May 18-19, 2022.

International Conference on Pharmacognosy

March 3-4, 2022 | France

Pharmaceutical and Pharmacognosy Sciences has wide scope in the world, thus has a vast and growing pharmaceutical industry and therapeutics. Increasing number of hospitals, nursing homes and pharmaceuticals companies all over the world is a clear indication of the growing scope in this area. Clinical research is related to the effectiveness and testing of medications, diagnostic products, medical devices and treatment procedures for human use.

INTERNATIONAL CONFERENCE ON MEDICAL, BIOLOGICAL AND PHARMACEUTICAL SCIENCES ICMBPS

March 12-13, 2022 | Gambia

The INTERNATIONAL CONFERENCE ON MEDICAL, BIOLOGICAL AND PHARMACEUTICAL SCIENCES ICMBPS. It will be held on 12th - 13th-Mar-2022 at Banjul, Gambia.

PRE FILLED SYRINGES EAST COAST

April 25-26, 2022 | USA

The global pre-filled syringes market was valued at $1139.6 million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. With that in mind, the 9th annual Pre-Filled Syringes East Coast conference will bring together leading industry experts representing big pharma and device developers to discuss the key drivers accelerating the expansion of the industry.
More Past Conferences

Spotlight

Insights on Improving Global Drug Development from Bench to Commercialization

Although R&D spending on new drugs is high and the number of new INDs for small molecules and biologics continues to increase each year, the number of NDAs/BLAs submitted and approved by FDA has remained on average steady over the last 10 years.

resources

resource image

Free flowing amorphous solid dispersions for enhanced drug solubility

video

resource image

BUILDING RESILIENT SUPPLY CHAINS REVITALIZING AMERICAN MANUFACTURING AND FOSTERING BROAD-BASED GROWTH

whitePaper

resource image

Bridging the Gaps in Complex Patient Journeys by Enriching Data

Article